Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-12-17

Clinical Trial Update: Oral Dydrogesterone (OD) Versus Micronized Vaginal Progesterone (MVP) for Luteal Phase Support (LPS) in IVF/ICSI [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing oral dydrogesterone to micronized vaginal progesterone for luteal phase support in IVF/ICSI completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • micronized vaginal progesterone (progesterone)
  • oral dydrogesterone (dydrogesterone)

Snippet

Sponsor: CRG UZ Brussel | Conditions: Infertility, Female, Infertility | Phase 4 | Status: COMPLETED